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Background
Left ventricular ejection fraction (LVEF) is a strong
predictor of subsequent cardiovascular events in patients
with ischemic and non-ischemic cardiomyopathy. CMR
is an excellent technique for assessment of LVEF as well
as for the detection of myocardial scar. We sought to
evaluate if the presence of myocardial scarring in non-
ischemic cardiomyopathy could be an important predic-
tor of cardiovascular events.
Methods
Inclusion criteria were absence of coronary artery disease,
a diagnosis of cardiomyopathy and an LVEF ≤ 45%.
Patients with a diagnosis of infiltrative disorders, hyper-
trophic cardiomyopathy, or tachycardia-induced cardio-
myopathy were excluded. A total of 132 patients (with
greater than 12 months follow up) were analyzed. Ima-
ging was performed on a 1.5 Tesla Avanto, or 3.0 Tesla
Verio MRI scanner (Siemens Medical Solutions). Cine
images were performed using a steady state free preces-
sion pulse sequence. Delayed enhancement (DE) CMR
was performed 10 minutes after administration of 0.15
mmol/kg Gadopentetate Dimeglumine (Bayer Health-
Care) with typical in-plane resolution 18 x 2.0 mm, slice
thickness 6-7 mm. LV and RV volumes and EF were
analyzed by manual planimetry of endocardial contours
during end-diastole and end-systole. DE-CMR images
were analyzed to identify hyperenhanced myocardium
(> 2 SD of remote signal intensity). The primary outcome
was a combination of hospitalization for heart failure, LV
assist device (LVAD) implantation, cardiac transplant, or
death. Adjusted Kaplan-Meier curves were constructed
for groups with and without scar by CMR with p<0.05
considered significant. Multivariate logistic regression
analysis was performed.
Results
Patient’s demographics are shown in table. All baseline
demographic data were similar between patients with
and without scar by CMR. The adjusted event-free sur-
vival rate was significantly lower for patients with scar
compared to patients without scar by CMR at 2-years
(p=0.03) (graph). Mean scar burden was 3 ± 8% of LV.
On multivariable analysis, the presence of scar was an
independent predictor of events, HR 2.5(CI: 0.98-6.38,
p=0.04), but LVEF was not.
Conclusions
In non-ischemic cardiomyopathy the presence of LV
scar measured by DE-CMR is a stronger predictor of
cardiovascular events than LVEF.
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Table 1 Patient Characteristics
All Without Scar With scar p value
Patients (n) 132 65 67
Clinical characteristics
Age (years) 51 ± 12 51 ± 16 50 ± 12 0.7
BMI (kg/m2) 31 ± 9 30 ± 8 32 ± 9 0.6
Male gender (%) 75(57%) 32(49%) 43(64%) 0.06
Race
Caucasian (%) 70(53%) 36(56%) 34(51%) 0.8
Black (%) 35(27%) 17(26%) 18(27%) 0.9
Hispanic (%) 17(12%) 10(15%) 7(10%) 0.8
Other (%) 10(8%) 2(3%) 8(12%) 0.08
DM (%) 26(20%) 15(23%) 16(24%) 0.9
HTN (%) 45(34%) 26(40%) 29(43%) 0.5
CMR findings
LVEF(%) 31± 11% 33± 10 30± 10 0.09
Scar burden 3 ± 5 N/A 6 ± 6 N/A
Figure 1 Event-free survival in patients with and without scar by
CMR.
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